Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age
DI BERNSTEIN, VE SMITH, GM SCHIFF… - The Pediatric …, 1993 - journals.lww.com
The safety and immunogenicity of a booster dose of a new acellular pertussis component
diphtheria-tetanus toxoids-pertussis vaccine (DTaP) were compared with whole cell …
diphtheria-tetanus toxoids-pertussis vaccine (DTaP) were compared with whole cell …
Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children
ME PICHICHERO, JL GREEN… - The Pediatric …, 1994 - journals.lww.com
An acellular pertussis vaccine (DTaP) containing pertussis toxoid, filamentous
hemagglutinin and the 69-kDa outer membrane protein (pertactin) was compared with …
hemagglutinin and the 69-kDa outer membrane protein (pertactin) was compared with …
Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17− to 24-month-old children
M Glode, L Joffe, K Reisinger, M Blatter… - The Pediatric …, 1992 - journals.lww.com
A double-blind, randomized, controlled trial comparing 4 lots of acellular pertussis-
diphtheria tetanus toxoids vaccine (APDT) to whole cell DTP vaccine in 397 children was …
diphtheria tetanus toxoids vaccine (APDT) to whole cell DTP vaccine in 397 children was …
Safety and immunogenicity of acellular pertussis vaccine, combined with diphtheria and tetanus as the Japanese commercial Takeda vaccine, compared with the …
B WATSON, A CAWEIN, BL MCKEE… - The Pediatric …, 1992 - journals.lww.com
A double blind, randomized, controlled trial compared the safety and immunogenicity of an
acellular pertussis vaccine formulated at Lederle using the Takeda acellular pertussis …
acellular pertussis vaccine formulated at Lederle using the Takeda acellular pertussis …
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children
ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children
ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
Acellular pertussis vaccine as a booster dose for seventeen-to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four …
SA Halperin, E Mills, L Barreto, C Pim… - The Pediatric …, 1995 - journals.lww.com
The safety and immunogenicity of two formulations of an acellular pertussis vaccine as a
booster at 17 to 19 months of age were assessed in children immunized at 2, 4 and 6 …
booster at 17 to 19 months of age were assessed in children immunized at 2, 4 and 6 …
Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children
NNT Minh, K Edelman, Q He, MK Viljanen, H Arvilommi… - Vaccine, 1998 - Elsevier
235 healthy 10–12 years old school children were randomly immunized with either a
booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) …
booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) …
Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussisvs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a …
ME Pichichero, TJ BADGETT… - The Pediatric …, 1987 - journals.lww.com
An acellular pertussis vaccine principally containing two purified pertussis antigens,
filamentous hemagglutinin and lymphocytosis-promoting factor, combined with diphtheria …
filamentous hemagglutinin and lymphocytosis-promoting factor, combined with diphtheria …
Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United …
HH Bernstein, EP Rothstein, PP Associates… - Vaccine, 1995 - Elsevier
Five hundred and fifty-seven infants received either an acellular pertussis (DTaP) vaccine
containing pertussis toxoid (PT), filamentous hemagglutinin (FHA) and pertactin (PRN) or …
containing pertussis toxoid (PT), filamentous hemagglutinin (FHA) and pertactin (PRN) or …